Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.

Alvarez, J M

Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. [electronic resource] - The Journal of thoracic and cardiovascular surgery Sep 2001 - 457-63 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0022-5223

10.1067/mtc.2001.115701 doi


Aged
Aprotinin--therapeutic use
Aspirin--adverse effects
Blood Component Transfusion--statistics & numerical data
Combined Modality Therapy
Coronary Artery Bypass--adverse effects
Coronary Disease--drug therapy
Double-Blind Method
Drainage
Female
Hemoglobins--analysis
Hemostatics--therapeutic use
Humans
Infusions, Intravenous
Male
Mediastinum
Middle Aged
Platelet Aggregation Inhibitors--adverse effects
Postoperative Care--methods
Postoperative Hemorrhage--blood
Prospective Studies
Time Factors